-
BBC Dashboard
- Holdings
Virtus LifeSci Biotech Clinical Trials ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
DREYFUS GOVERNMENT CASH MANAGE | 754.96 k | 754.96 k shares | 6.67 | Short-term investment vehicle | Long | USA |
SRRK Scholar Rock Holding Corporation | 277.89 k | 9.77 k shares | 2.45 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals, Inc. | 275.79 k | 4.62 k shares | 2.44 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 211.74 k | 11.39 k shares | 1.87 | Common equity | Long | USA |
IGMS IGM Biosciences, Inc. | 198.93 k | 11.61 k shares | 1.76 | Common equity | Long | USA |
WVE Wave Life Sciences Ltd. | 194.98 k | 14.22 k shares | 1.72 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 172.72 k | 5.15 k shares | 1.53 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 160.77 k | 2.30 k shares | 1.42 | Common equity | Long | USA |
APLT Applied Therapeutics, Inc. | 154.91 k | 17.52 k shares | 1.37 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 151.23 k | 7.01 k shares | 1.34 | Common equity | Long | USA |
CNTA Centessa Pharmaceuticals plc | 139.65 k | 9.29 k shares | 1.23 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 139.13 k | 1.65 k shares | 1.23 | Common equity | Long | USA |
Zymeworks Inc. | 138.56 k | 10.11 k shares | 1.22 | Common equity | Long | USA |
BHVN Biohaven Ltd. | 137.34 k | 2.76 k shares | 1.21 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 135.48 k | 5.51 k shares | 1.20 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 132.30 k | 1.24 k shares | 1.17 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 128.47 k | 1.77 k shares | 1.13 | Common equity | Long | USA |
PHVS Pharvaris N.V. | 126.56 k | 5.09 k shares | 1.12 | Common equity | Long | Netherlands |
RVMD Revolution Medicines, Inc. | 124.17 k | 2.32 k shares | 1.10 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 122.85 k | 2.68 k shares | 1.09 | Common equity | Long | USA |
BLTE Belite Bio, Inc | 122.76 k | 1.84 k shares | 1.08 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 121.89 k | 2.64 k shares | 1.08 | Common equity | Long | USA |
SLRN Acelyrin, Inc. | 120.06 k | 21.14 k shares | 1.06 | Common equity | Long | USA |
SAVA Cassava Sciences, Inc. | 119.58 k | 4.63 k shares | 1.06 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 117.96 k | 10.27 k shares | 1.04 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 117.59 k | 2.18 k shares | 1.04 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 116.64 k | 4.19 k shares | 1.03 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 115.34 k | 3.74 k shares | 1.02 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 114.53 k | 9.74 k shares | 1.01 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 112.87 k | 2.05 k shares | 1.00 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 112.53 k | 12.00 k shares | 0.99 | Common equity | Long | USA |
ANNX Annexon, Inc. | 112.28 k | 15.34 k shares | 0.99 | Common equity | Long | USA |
ABUS Arbutus Biopharma Corporation | 112.13 k | 29.16 k shares | 0.99 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 111.26 k | 2.14 k shares | 0.98 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 109.79 k | 1.96 k shares | 0.97 | Common equity | Long | USA |
ERAS Erasca, Inc. | 109.49 k | 42.28 k shares | 0.97 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 108.30 k | 7.70 k shares | 0.96 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 108.10 k | 4.16 k shares | 0.95 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 107.90 k | 1.86 k shares | 0.95 | Common equity | Long | USA |
NMRA Neumora Therapeutics, Inc. Common Stock | 106.04 k | 9.26 k shares | 0.94 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 105.46 k | 2.35 k shares | 0.93 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 104.68 k | 5.37 k shares | 0.92 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 103.09 k | 1.17 k shares | 0.91 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 101.30 k | 3.46 k shares | 0.89 | Common equity | Long | USA |
QURE uniQure N.V. | 100.42 k | 17.56 k shares | 0.89 | Common equity | Long | Netherlands |
MLTX MoonLake Immunotherapeutics | 100.36 k | 2.16 k shares | 0.89 | Common equity | Long | Switzerland |
XENE Xenon Pharmaceuticals Inc. | 99.69 k | 2.42 k shares | 0.88 | Common equity | Long | Canada |
VERA Vera Therapeutics, Inc. | 99.54 k | 2.47 k shares | 0.88 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 97.41 k | 2.31 k shares | 0.86 | Common equity | Long | USA |
MLYS Mineralys Therapeutics, Inc. | 97.23 k | 7.27 k shares | 0.86 | Common equity | Long | USA |
NGNE Neurogene Inc. | 96.56 k | 2.19 k shares | 0.85 | Common equity | Long | USA |
DNTH Dianthus Therapeutics, Inc. | 95.34 k | 3.42 k shares | 0.84 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 94.29 k | 16.45 k shares | 0.83 | Common equity | Long | USA |
EXAI Exscientia plc | 94.08 k | 19.36 k shares | 0.83 | Common equity | Long | UK |
CGON CG Oncology, Inc. Common stock | 94.08 k | 2.65 k shares | 0.83 | Common equity | Long | USA |
LNTH Lantheus Holdings, Inc. | 93.83 k | 7.95 k shares | 0.83 | Common equity | Long | USA |
CELC Celcuity Inc. | 93.09 k | 6.01 k shares | 0.82 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 92.71 k | 36.28 k shares | 0.82 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 92.65 k | 2.85 k shares | 0.82 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 92.13 k | 3.49 k shares | 0.81 | Common equity | Long | USA |
ALEC Alector, Inc. | 91.99 k | 18.70 k shares | 0.81 | Common equity | Long | USA |
XNCR Xencor, Inc. | 90.83 k | 4.32 k shares | 0.80 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 89.10 k | 1.75 k shares | 0.79 | Common equity | Long | USA |
BCYC Bicycle Therapeutics plc | 88.83 k | 3.79 k shares | 0.78 | Common equity | Long | UK |
OLMA Olema Pharmaceuticals, Inc. | 85.25 k | 7.39 k shares | 0.75 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 83.95 k | 4.45 k shares | 0.74 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 82.99 k | 5.42 k shares | 0.73 | Common equity | Long | USA |
SVRA Savara Inc. | 82.52 k | 22.70 k shares | 0.73 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 82.13 k | 3.80 k shares | 0.73 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 81.99 k | 9.87 k shares | 0.72 | Common equity | Long | USA |
SLN Silence Therapeutics plc | 80.86 k | 4.67 k shares | 0.71 | Common equity | Long | UK |
NAMS NewAmsterdam Pharma Company N.V. | 80.64 k | 4.74 k shares | 0.71 | Common equity | Long | Netherlands |
BEAM Beam Therapeutics Inc. | 80.04 k | 3.65 k shares | 0.71 | Common equity | Long | USA |
MRUS Merus N.V. | 79.64 k | 1.60 k shares | 0.70 | Common equity | Long | Netherlands |
TERN Terns Pharmaceuticals, Inc. | 79.23 k | 11.55 k shares | 0.70 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 78.96 k | 2.74 k shares | 0.70 | Common equity | Long | USA |
LRMR Larimar Therapeutics, Inc. | 78.20 k | 9.51 k shares | 0.69 | Common equity | Long | USA |
TYRA Tyra Biosciences, Inc. | 77.43 k | 4.64 k shares | 0.68 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 77.20 k | 9.92 k shares | 0.68 | Common equity | Long | USA |
ABCL AbCellera Biologics Inc. | 75.56 k | 27.68 k shares | 0.67 | Common equity | Long | Canada |
Liquidia Corporation | 74.43 k | 6.86 k shares | 0.66 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 73.54 k | 1.79 k shares | 0.65 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 73.36 k | 4.32 k shares | 0.65 | Common equity | Long | Ireland |
MGNX MacroGenics, Inc. | 72.08 k | 19.69 k shares | 0.64 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 71.48 k | 4.28 k shares | 0.63 | Common equity | Long | USA |
AUTL Autolus Therapeutics plc | 68.57 k | 20.35 k shares | 0.61 | Common equity | Long | UK |
NUVB Nuvation Bio Inc. | 68.11 k | 30.82 k shares | 0.60 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 67.07 k | 4.03 k shares | 0.59 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 66.88 k | 3.48 k shares | 0.59 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 66.69 k | 2.37 k shares | 0.59 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 66.62 k | 8.89 k shares | 0.59 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 66.39 k | 11.78 k shares | 0.59 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 65.91 k | 2.53 k shares | 0.58 | Common equity | Long | USA |
IMNM Immunome, Inc. | 65.87 k | 5.74 k shares | 0.58 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 65.75 k | 4.23 k shares | 0.58 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 64.96 k | 5.26 k shares | 0.57 | Common equity | Long | USA |
IMTX Immatics N.V. | 64.75 k | 7.12 k shares | 0.57 | Common equity | Long | Germany |
CMPS COMPASS Pathways plc | 63.22 k | 13.28 k shares | 0.56 | Common equity | Long | UK |
CVAC CureVac N.V. | 63.12 k | 23.04 k shares | 0.56 | Common equity | Long | Germany |
RXRX Recursion Pharmaceuticals, Inc. | 61.70 k | 9.76 k shares | 0.55 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 60.50 k | 7.04 k shares | 0.53 | Common equity | Long | USA |
TNGX Tango Therapeutics, Inc. | 59.70 k | 10.98 k shares | 0.53 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 51.75 k | 2.92 k shares | 0.46 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 50.48 k | 3.55 k shares | 0.45 | Common equity | Long | USA |
EDIT Editas Medicine, Inc. | 48.69 k | 16.79 k shares | 0.43 | Common equity | Long | USA |
ITOS iTeos Therapeutics, Inc. | 47.78 k | 5.66 k shares | 0.42 | Common equity | Long | USA |
PRME Prime Medicine, Inc. | 45.28 k | 11.67 k shares | 0.40 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 45.12 k | 12.89 k shares | 0.40 | Common equity | Long | USA |
PGEN Precigen, Inc. | 42.73 k | 54.22 k shares | 0.38 | Common equity | Long | USA |
TSHA Taysha Gene Therapies, Inc. | 37.35 k | 22.10 k shares | 0.33 | Common equity | Long | USA |
FULC Fulcrum Therapeutics, Inc. | 37.33 k | 11.81 k shares | 0.33 | Common equity | Long | USA |
LYEL Lyell Immunopharma, Inc. | 34.17 k | 35.58 k shares | 0.30 | Common equity | Long | USA |
KYTX Kyverna Therapeutics, Inc. | 30.50 k | 6.38 k shares | 0.27 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 30.22 k | 3.77 k shares | 0.27 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 26.43 k | 9.68 k shares | 0.23 | Common equity | Long | USA |
CABA Cabaletta Bio, Inc. | 26.05 k | 7.34 k shares | 0.23 | Common equity | Long | USA |
AGEN Agenus Inc. | 24.19 k | 5.76 k shares | 0.21 | Common equity | Long | USA |
ALXO ALX Oncology Holdings Inc. | 15.62 k | 10.92 k shares | 0.14 | Common equity | Long | USA |
SCLX Scilex Holding Company | 15.52 k | 17.95 k shares | 0.14 | Common equity | Long | USA |
HLVX HilleVax, Inc. | 11.28 k | 6.23 k shares | 0.10 | Common equity | Long | USA |
AVTE Aerovate Therapeutics, Inc. | 9.19 k | 3.75 k shares | 0.08 | Common equity | Long | USA |